Our work: details

One of the possible effects of chemotherapy is the suppression of the immune system. As a result, even a mild illness can put patients at risk of developing a condition called neutropenic sepsis (NS), a life-threatening medical emergency. If patients have any signs of an infection, they have to be rapidly brought to hospital to undergo a blood test. While the healthcare team awaits results for 1-2 hours, the patient is given intravenous antibiotics as a precaution, because delays to treatment increase the risk of death. However, around 50% of these patients brought into hospital turn out not to have NS – and therefore did not need to attend hospital or have antibiotics.
 
At Neutrocheck we want to give patients back some peace of mind. To achieve this, we are developing a fast, reliable and low-cost device to test for NS symptoms at home, improving patient safety and quality of life, reducing antibiotic wastage, and empowering doctors to treat their patients efficiently.

pain-01.png
iv_up-01.png
rush-01.png
bench-01.png

For patients, Neutrocheck has the potential to 

  • Reduce mortality risk

  • Reduce the number of trips to hospital

  • Provide peace of mind

  • Reduce antibiotic resistance

For nurses and doctors, Neutrocheck has the potential to

  • Aid triaging decisions

  • Reduce case-load in emergency rooms

  • Reduce patient mortality

  • Reduce antibiotic resistance

For providers, Neutrocheck has the potential to

  • Free-up emergency room and acute resources

  • Reduce costs

  • Improve patient outcomes

  • Reduce antibiotic resistance

For payers, Neutrocheck has the potential to

  • Reduce costs

  • Improve patient outcomes

  • Reduce antibiotic resistance

If you would like to learn more about Neutrocheck, contact us.